Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hartung

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Anti-Cancer Drugs|December 24, 1997
Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing ratsG Stehle, A Wunder, H Sinn, et al.
Onkologie|July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II TrialG. Hartung, R. Hofheinz, D. Buchheidt, et al.
Investigational New Drugs|July 14, 2005
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: a phase II study group trial of the Central European Society of Anticancer-Drug Research (CESAR)R-D Hofheinz, C Porta, G Hartung, et al.
Onkologie|November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancerG Hartung, R D Hofheinz, A Wein, et al.
British Journal of Cancer|July 9, 2004
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trialR-D Hofheinz, J T Hartmann, A Willer, et al.
Onkologie|March 8, 2003
Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancerR-D Hofheinz, S-E al-Batran, F Hartmann, et al.
European Journal of Haematology|February 14, 2004
Treatment with campath-1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHDDaniel Wolff, B Steiner, S Stilgenbauer, et al.
Bone Marrow Transplantation|September 5, 2006
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host diseaseD Wolff, S Wilhelm, J Hahn, et al.
Bone Marrow Transplantation|April 5, 2005
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanerceptD Wolff, V Roessler, B Steiner, et al.
Deutsche Medizinische Wochenschrift (1946)|September 21, 2005
[Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine]J Casper, S Wilhelm, B Steiner, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Anti-Cancer Drugs|December 24, 1997
Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing ratsG Stehle, A Wunder, H Sinn, et al.
Onkologie|July 7, 2001
Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II TrialG. Hartung, R. Hofheinz, D. Buchheidt, et al.
Investigational New Drugs|July 14, 2005
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: a phase II study group trial of the Central European Society of Anticancer-Drug Research (CESAR)R-D Hofheinz, C Porta, G Hartung, et al.
Onkologie|November 6, 2001
Phase II study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancerG Hartung, R D Hofheinz, A Wein, et al.
British Journal of Cancer|July 9, 2004
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trialR-D Hofheinz, J T Hartmann, A Willer, et al.
Onkologie|March 8, 2003
Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancerR-D Hofheinz, S-E al-Batran, F Hartmann, et al.
European Journal of Haematology|February 14, 2004
Treatment with campath-1H for relapsed chronic lymphocytic leukemia after allogeneic peripheral blood stem cell transplantation does not abrogate the development of chronic GVHDDaniel Wolff, B Steiner, S Stilgenbauer, et al.
Bone Marrow Transplantation|September 5, 2006
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host diseaseD Wolff, S Wilhelm, J Hahn, et al.
Bone Marrow Transplantation|April 5, 2005
Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanerceptD Wolff, V Roessler, B Steiner, et al.
Deutsche Medizinische Wochenschrift (1946)|September 21, 2005
[Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine]J Casper, S Wilhelm, B Steiner, et al.
Pageof 5